Package 72162-2570-3

Brand: darifenacin

Generic: darifenacin
NDC Package

Package Facts

Identity

Package NDC 72162-2570-3
Digits Only 7216225703
Product NDC 72162-2570
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2570-3)

Marketing

Marketing Status
Marketed Since 2025-11-17
Brand darifenacin
Generic darifenacin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2a6e97d9-19e4-42aa-86e8-27bab91f059d", "openfda": {"unii": ["CR02EYQ8GV"], "rxcui": ["485423"], "spl_set_id": ["697eba55-9e1f-4036-baed-5644c810f166"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2570-3)", "package_ndc": "72162-2570-3", "marketing_start_date": "20251117"}], "brand_name": "Darifenacin", "product_id": "72162-2570_2a6e97d9-19e4-42aa-86e8-27bab91f059d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "72162-2570", "generic_name": "Darifenacin", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darifenacin", "active_ingredients": [{"name": "DARIFENACIN HYDROBROMIDE", "strength": "7.5 mg/1"}], "application_number": "ANDA205209", "marketing_category": "ANDA", "marketing_start_date": "20161118", "listing_expiration_date": "20261231"}